Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment

I. Rebollo-Mesa, E. Nova-Lamperti, P. Mobillo, M. Runglall, S. Christakoudi, S. Norris, N. Smallcombe, Y. Kamra, R. Hilton, . , S. Bhandari, R. Baker, D. Berglund, S. Carr, D. Game, S. Griffin, PA. Kalra, R. Lewis, PB. Mark, S. Marks, I. Macphee,...

. 2016 ; 16 (12) : 3443-3457. [pub] 20160808

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011150

We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell-related genes and the relative expansions of B cell subsets. However, in all of these studies, the index group-namely, the tolerant recipients-were not receiving immunosuppression (IS) treatment, unlike the rest of the comparator groups. We aimed to assess the confounding effect of these regimens and develop a novel IS-independent signature of tolerance. Analyzing gene expression in three independent kidney transplant patient cohorts (232 recipients and 14 tolerant patients), we have established that the expression of the previously reported signature was biased by IS regimens, which also influenced transitional B cells. We have defined and validated a new gene expression signature that is independent of drug effects and also differentiates tolerant patients from healthy controls (cross-validated area under the receiver operating characteristic curve [AUC] = 0.81). In a prospective cohort, we have demonstrated that the new signature remained stable before and after steroid withdrawal. In addition, we report on a validated and highly accurate gene expression signature that can be reliably used to identify patients suitable for IS reduction (approximately 12% of stable patients), irrespective of the IS drugs they are receiving. Only a similar approach will make the conduct of pilot clinical trials for IS minimization safe and hence allow critical improvements in kidney posttransplant management.

Cardiff and Vale University Health Board Cardiff United Kingdom

Evelina London Children's Hospital London United Kingdom

Great Ormond Street Hospital for Children NHS Foundation Trust London United Kingdom

Guy's and St Thomas' NHS Foundation Trust London United Kingdom

Hospital Universitari Vall d'Hebr_on Barcelona Spain

Hull and East Yorkshire Hospitals NHS Trust Hull United Kingdom

INSELSPITAL Universitätsspital Bern Klinik für Nephrologie Hypertonie Abteilung für Hypertonie Bern Switzerland

King's College Hospital NHS Foundation Trust London United Kingdom

Leicester General Hospital Leicester United Kingdom

Manchester Royal Infirmary Manchester United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom Biostatistics Institute of Psychiatry Psychology and Neuroscience King's College London London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom Biostatistics Institute of Psychiatry Psychology and Neuroscience King's College London London United Kingdom UCB Celltech UCB Pharma S A Slough United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom King's Health Partners London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom National Institute for Health Research Biomedical Research Centre Guy's and St Thomas' National Health Service Foundation Trust King's College London London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom National Institute for Health Research Biomedical Research Centre Guy's and St Thomas' National Health Service Foundation Trust King's College London London United Kingdom Guy's and St Thomas' NHS Foundation Trust London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom Peter Gorer Department of Immunobiology King's College London London United Kingdom

Medical Research Council Centre for Transplantation King's College London London United Kingdom University College London London United Kingdom

National Institute for Health Research Biomedical Research Centre Guy's and St Thomas' National Health Service Foundation Trust King's College London London United Kingdom

Northern General Hospital Sheffield United Kingdom

Queen Alexandra Hospital Portsmouth United Kingdom

Salford Royal Hospital Salford United Kingdom

St George's Hospital London United Kingdom

St James's University Hospital Leeds United Kingdom

Transplantační laboratoř IKEM Prague Czech Republic

University of Glasgow Glasgow United Kingdom

Uppsala University Hospital Uppsala Sweden

000      
00000naa a2200000 a 4500
001      
bmc18011150
003      
CZ-PrNML
005      
20210317132204.0
007      
ta
008      
180404s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ajt.13932 $2 doi
035    __
$a (PubMed)27328267
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rebollo-Mesa, I $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. UCB Celltech, UCB Pharma S.A., Slough, United Kingdom.
245    10
$a Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment / $c I. Rebollo-Mesa, E. Nova-Lamperti, P. Mobillo, M. Runglall, S. Christakoudi, S. Norris, N. Smallcombe, Y. Kamra, R. Hilton, . , S. Bhandari, R. Baker, D. Berglund, S. Carr, D. Game, S. Griffin, PA. Kalra, R. Lewis, PB. Mark, S. Marks, I. Macphee, W. McKane, MG. Mohaupt, R. Pararajasingam, SP. Kon, D. Serón, MD. Sinha, B. Tucker, O. Viklický, RI. Lechler, GM. Lord, MP. Hernandez-Fuentes,
520    9_
$a We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell-related genes and the relative expansions of B cell subsets. However, in all of these studies, the index group-namely, the tolerant recipients-were not receiving immunosuppression (IS) treatment, unlike the rest of the comparator groups. We aimed to assess the confounding effect of these regimens and develop a novel IS-independent signature of tolerance. Analyzing gene expression in three independent kidney transplant patient cohorts (232 recipients and 14 tolerant patients), we have established that the expression of the previously reported signature was biased by IS regimens, which also influenced transitional B cells. We have defined and validated a new gene expression signature that is independent of drug effects and also differentiates tolerant patients from healthy controls (cross-validated area under the receiver operating characteristic curve [AUC] = 0.81). In a prospective cohort, we have demonstrated that the new signature remained stable before and after steroid withdrawal. In addition, we report on a validated and highly accurate gene expression signature that can be reliably used to identify patients suitable for IS reduction (approximately 12% of stable patients), irrespective of the IS drugs they are receiving. Only a similar approach will make the conduct of pilot clinical trials for IS minimization safe and hence allow critical improvements in kidney posttransplant management.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a B-lymfocyty $x účinky léků $x imunologie $x metabolismus $7 D001402
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a hodnoty glomerulární filtrace $7 D005919
650    _2
$a rejekce štěpu $x diagnóza $x farmakoterapie $x etiologie $x metabolismus $7 D006084
650    _2
$a přežívání štěpu $x účinky léků $x imunologie $7 D006085
650    _2
$a lidé $7 D006801
650    _2
$a imunologická tolerance $x účinky léků $x imunologie $7 D007108
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a chronické selhání ledvin $x komplikace $x chirurgie $7 D007676
650    _2
$a vyšetření funkce ledvin $7 D007677
650    _2
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nova-Lamperti, E $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
700    1_
$a Mobillo, P $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
700    1_
$a Runglall, M $u National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom.
700    1_
$a Christakoudi, S $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
700    1_
$a Norris, S $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. University College London, London, United Kingdom.
700    1_
$a Smallcombe, N $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom.
700    1_
$a Kamra, Y $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.
700    1_
$a Hilton, R $u Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
700    1_
$a , $u King's College London, London, United Kingdom. Oxford University, Oxford, United Kingdom. Imperial College London, London, United Kingdom. Institute for Medical Immunology, Université Libre de Bruxelles, Bruxelles, Belgium. Miltenyi Biotec, Bergisch Gladbach, Germany. University of Nantes, Nantes, France. Charité, Universitaatsmedizin Berlin, Berlin, Germany.
700    1_
$a Bhandari, S $u Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
700    1_
$a Baker, R $u St. James's University Hospital, Leeds, United Kingdom.
700    1_
$a Berglund, D $u Uppsala University Hospital, Uppsala, Sweden.
700    1_
$a Carr, S $u Leicester General Hospital, Leicester, United Kingdom.
700    1_
$a Game, D $u Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
700    1_
$a Griffin, S $u Cardiff and Vale University Health Board, Cardiff, United Kingdom.
700    1_
$a Kalra, P A $u Salford Royal Hospital, Salford, United Kingdom.
700    1_
$a Lewis, R $u Queen Alexandra Hospital, Portsmouth, United Kingdom.
700    1_
$a Mark, P B $u University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Marks, S $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
700    1_
$a MacPhee, Iain A. M., $7 xx0232048 $u St. George's Hospital, London, United Kingdom.
700    1_
$a McKane, W $u Northern General Hospital, Sheffield, United Kingdom.
700    1_
$a Mohaupt, M G $u INSELSPITAL, Universitätsspital Bern, Klinik für Nephrologie/Hypertonie Abteilung für Hypertonie, Bern, Switzerland.
700    1_
$a Pararajasingam, R $u Manchester Royal Infirmary, Manchester, United Kingdom.
700    1_
$a Kon, S P $u King's College Hospital NHS Foundation Trust, London, United Kingdom.
700    1_
$a Serón, D $u Hospital Universitari Vall d'Hebr_on, Barcelona, Spain.
700    1_
$a Sinha, M D $u Evelina London Children's Hospital, London, United Kingdom.
700    1_
$a Tucker, B $u King's College Hospital NHS Foundation Trust, London, United Kingdom.
700    1_
$a Viklický, O $u Transplantační laboratoř IKEM, Prague, Czech Republic.
700    1_
$a Lechler, Robert, $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. King's Health Partners, London, United Kingdom. $d 1951- $7 xx0258392
700    1_
$a Lord, G M $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom. Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
700    1_
$a Hernandez-Fuentes, M P $u Medical Research Council Centre for Transplantation, King's College London, London, United Kingdom. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, United Kingdom.
773    0_
$w MED00006447 $t American journal of transplantation official journal of the American Society of Transplantation and the American Society of Transplant Surgeons $x 1600-6143 $g Roč. 16, č. 12 (2016), s. 3443-3457
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27328267 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20210317132115 $b ABA008
999    __
$a ok $b bmc $g 1288635 $s 1007962
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c 12 $d 3443-3457 $e 20160808 $i 1600-6143 $m American journal of transplantation $n Am J Transplant $x MED00006447
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...